Maleimide-Val-Ala-PAB-SNS032 is a cleavable ADC linker-toxin conjugate. SNS-032, a CDK inhibitor, halts the cell cycle at G1/S phase, reducing cancer cell viability. The Maleimide-Val-Ala-PAB linker enables ADC synthesis for targeted drug delivery. Reagent grade, for research purpose.
Usually ships within 24 hours.